Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2026-06-16 @ 2:10 AM
Study NCT ID:
NCT05581004
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2022-10-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Sponsor:
Genentech, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Locally Advanced or Metastatic Solid Tumors | View |
| None | NSCLC | View |
| None | HNSCC | View |
| None | Melanoma | View |
| None | TNBC | View |
| None | Esophageal Cancer | View |
| None | Gastric Cancer | View |
| None | Cervical Cancer | View |
| None | Colorectal Cancer | View |
| None | Urothelial Carcinoma | View |
| None | Clear Cell RCC | View |
| None | HCC | View |
Keywords: